
Browse by Nurse Practitioner Items
Nurse practitioner PBS prescribing
MEDICINES WHICH MAY BE PRESCRIBED BY AUTHORISED NURSE PRACTITIONERS
From 1 September 2010, nurse practitioners endorsed to prescribe under state or territory legislation can apply for approval as PBS prescribers (authorised nurse practitioners). Information for nurse practitioners to become authorised PBS prescribers is available from Department of Human Services.
The medicines listed for prescribing by authorised nurse practitioners fron 1 November 2010 are identified by ‘NP’ in the PBS Schedule. Nurse practitioners must not write PBS prescriptions for other medicines.
PBS prescribing is limited by a nurse practitioner’s scope of practice, and state and territory prescribing rights. Prescribing of PBS medicines is also contingent on a prescriber being an authorised nurse practitioner and having collaborative arrangements in place, as required by amendments to the National Health Act 1953.
The Pharmaceutical Benefits Advisory Committee (PBAC) is responsible for making recommendations to the Minister for Health and Ageing regarding medicines for prescribing by authorised nurse practitioners.
Further to prescribing within collaborative arrangements, certain medicines also have additional conditions for prescribing by nurse practitioners, as recommended by the PBAC. These medicines are identified by the codes ‘CTO’ for continuation therapy only or ‘SCM’ for prescribing within a shared care model, as outlined below:
- Continuing therapy only model
Where the patient’s treatment and prescribing of a medicine has been initiated by a medical practitioner, but prescribing is continued by a nurse practitioner. (This is similar to existing arrangements between specialists and medical practitioners for prescribing certain medicines.)
- Shared care model
Where care is shared between a nurse practitioner and medical practitioner in a formalised arrangement with an agreed plan to manage the patient, in a patientcentred model of care. The details surrounding shared care arrangements will depend on the practitioners involved, patient needs and the healthcare context.
Some medicines are included in more than one section of the Schedule, and for more than one prescriber type. For a prescription to be eligible for subsidy, prescribers must ensure that they prescribe under the PBS only those medicines, and in accordance with the restrictions, listed for their prescriber type. Listing details for the same product may differ between sections and different PBS item codes apply for each prescriber type.
Nurse practitioner PBS prescriptions are identifiable by colour, and include the indicator ‘NP’ on personalised forms and a tick box on non-personalised (blank) forms.
Prescriptions must include the nurse practitioner’s PBS prescriber number. For unrestricted and restricted PBS medicines, midwives/nurse practitioners can use the personalised or non-personalised PBS prescriber forms. For authority required and authority required (streamlined) PBS medicines, midwives/nurse practitioners can use the authority personalised or non-personalised PBS prescriber forms. Nurse practitioner PBS prescriptions may include repeats.
Regulation 24 applies for nurse practitioner prescribing. A nurse practitioner can direct that original and repeat supplies of pharmaceutical benefits be supplied at the one time, if certain conditions are satisfied.
Authority prescriptions: Authority prescriptions for authority required items, or for increased quantities or repeats, require prior approval from Department of Human Services for each prescription. (Refer to Prescribing Medicines — Information for PBS prescribers and Supplying medicines — What Pharmacists Need to Know, for more information on authority prescriptions.)
State and territory requirements: Nurse practitioners may prescribe medicines as private prescriptions according to their state/territory prescribing accreditation. The medicines which can be prescribed differ between states and territories. It is the nurse practitioner’s responsibility to ensure adherence to State/Territory law for all prescriptions (PBS and private) and additionally to all PBS requirements for PBS prescriptions.
Refine SEARCH
Legend
- P
- Palliative care items
- MP
- Medical Practitioner
- MW
- Midwife
- NP
- Nurse Practitioner
| Prescriber code | Item code | Name, manner of administration and form & strength | Max qty packs |
Max qty units |
No. of repeats |
|---|---|---|---|---|---|
| MPNP | 8092X | FAMCICLOVIRfamciclovir 125 mg tablet, 40 | 1 | 40 | 1 |
| MPNP | 2274Q | FAMCICLOVIRfamciclovir 250 mg tablet, 20 | 1 | 20 | 1 |
| MPNP | 8002E | FAMCICLOVIRfamciclovir 250 mg tablet, 21 | 1 | 21 | 0 |
| MPNP | 8217L | FAMCICLOVIRfamciclovir 250 mg tablet, 56 | 1 | 56 | 5 |
| MPNP | 8897G | FAMCICLOVIRfamciclovir 500 mg tablet, 30 | 1 | 30 | 0 |
| MPNP | 8896F | FAMCICLOVIRfamciclovir 500 mg tablet, 56 | 1 | 56 | 5 |
| MPNP | 2487X | FAMOTIDINEfamotidine 20 mg tablet, 60 | 1 | 60 | 5 |
| MPNP | 2488Y | FAMOTIDINEfamotidine 40 mg tablet, 30 | 1 | 30 | 5 |
| MPNP | 2367N | FELODIPINEfelodipine 10 mg tablet: modified release, 30 tablets | 1 | 30 | 5 |
| MPNP | 2361G | FELODIPINEfelodipine 2.5 mg tablet: modified release, 30 tablets | 1 | 30 | 5 |
| MPNP | 2366M | FELODIPINEfelodipine 5 mg tablet: modified release, 30 tablets | 1 | 30 | 5 |
| MPNP | 9023X | FENOFIBRATEfenofibrate 145 mg tablet, 30 | 1 | 30 | 5 |
| MPNP | 9022W | FENOFIBRATEfenofibrate 48 mg tablet, 60 | 1 | 60 | 5 |
| MPNP | 5411T | FENTANYLFENTANYL Lozenge 1200 micrograms (as citrate), 30 | 2 | 60 | 0 |
| MPNP | 5405L | FENTANYLFENTANYL Lozenge 1200 micrograms (as citrate), 9 | 1 | 9 | 0 |
| MPNP | 5412W | FENTANYLFENTANYL Lozenge 1600 micrograms (as citrate), 30 | 2 | 60 | 0 |
| MPNP | 5406M | FENTANYLFENTANYL Lozenge 1600 micrograms (as citrate), 9 | 1 | 9 | 0 |
| MPNP | 5407N | FENTANYLFENTANYL Lozenge 200 micrograms (as citrate), 30 | 2 | 60 | 0 |
| MPNP | 5401G | FENTANYLFENTANYL Lozenge 200 micrograms (as citrate), 9 | 1 | 9 | 0 |
| MPNP | 5408P | FENTANYLFENTANYL Lozenge 400 micrograms (as citrate), 30 | 2 | 60 | 0 |
| MPNP | 5402H | FENTANYLFENTANYL Lozenge 400 micrograms (as citrate), 9 | 1 | 9 | 0 |
| MPNP | 5409Q | FENTANYLFENTANYL Lozenge 600 micrograms (as citrate), 30 | 2 | 60 | 0 |
| MPNP | 5403J | FENTANYLFENTANYL Lozenge 600 micrograms (as citrate), 9 | 1 | 9 | 0 |
| MPNP | 5410R | FENTANYLFENTANYL Lozenge 800 micrograms (as citrate), 30 | 2 | 60 | 0 |
| MPNP | 5404K | FENTANYLFENTANYL Lozenge 800 micrograms (as citrate), 9 | 1 | 9 | 0 |
| MPNP | 5280X | FENTANYLfentanyl 100 microgram/hour patch, 5 | 1 | 5 | 0 |
| MPNP | 5441J | FENTANYLfentanyl 100 microgram/hour patch, 5 | 1 | 5 | 0 |
| MPNP | 8894D | FENTANYLfentanyl 100 microgram/hour patch, 5 | 1 | 5 | 0 |
| MPNP | 5265D | FENTANYLfentanyl 12 microgram/hour patch, 5 | 1 | 5 | 0 |
| MPNP | 5437E | FENTANYLfentanyl 12 microgram/hour patch, 5 | 1 | 5 | 0 |
| MPNP | 8878G | FENTANYLfentanyl 12 microgram/hour patch, 5 | 1 | 5 | 0 |
| MPNP | 5277R | FENTANYLfentanyl 25 microgram/hour patch, 5 | 1 | 5 | 0 |
| MPNP | 5438F | FENTANYLfentanyl 25 microgram/hour patch, 5 | 1 | 5 | 0 |
| MPNP | 8891Y | FENTANYLfentanyl 25 microgram/hour patch, 5 | 1 | 5 | 0 |
| MPNP | 5278T | FENTANYLfentanyl 50 microgram/hour patch, 5 | 1 | 5 | 0 |
| MPNP | 5439G | FENTANYLfentanyl 50 microgram/hour patch, 5 | 1 | 5 | 0 |
| MPNP | 8892B | FENTANYLfentanyl 50 microgram/hour patch, 5 | 1 | 5 | 0 |
| MPNP | 5279W | FENTANYLfentanyl 75 microgram/hour patch, 5 | 1 | 5 | 0 |
| MPNP | 5440H | FENTANYLfentanyl 75 microgram/hour patch, 5 | 1 | 5 | 0 |
| MPNP | 8893C | FENTANYLfentanyl 75 microgram/hour patch, 5 | 1 | 5 | 0 |
| MPNP | 8985X | FERROUS FUMARATEferrous fumarate 200 mg (equivalent to 65.7 mg of elemental iron) tablet, 60 | 1 | 60 | 1 |
| MPNP | 9011G | FERROUS FUMARATE + FOLIC ACIDferrous fumarate 310 mg (equivalent to 100 mg elemental iron) + folic acid 350 microgram tablet, 60 | 1 | 60 | 1 |
| MPNP | 8815Y | FERROUS SULFATEferrous sulfate 30 mg/mL (equivalent to 6 mg/mL elemental iron) oral liquid, 250 mL | 1 | 1 | 2 |
| MPNP | 1090J | FLECAINIDEflecainide acetate 100 mg tablet, 60 | 1 | 60 | 5 |
| MPNP | 1088G | FLECAINIDEflecainide acetate 50 mg tablet, 60 | 1 | 60 | 5 |
| MPNP | 1525G | FLUCLOXACILLINflucloxacillin 1 g injection, 5 x 1 g vials | 1 | 5 | 1 |
| MPNP | 9149M | FLUCLOXACILLINflucloxacillin 125 mg/5 mL oral liquid: powder for, 100 mL | 1 | 1 | 0 |
| MPMWNP | 1526H | FLUCLOXACILLINflucloxacillin 250 mg capsule, 24 | 1 | 24 | 0 |
| MPNP | 9150N | FLUCLOXACILLINflucloxacillin 250 mg/5 mL oral liquid: powder for, 100 mL | 1 | 1 | 0 |
| MPMWNP | 1527J | FLUCLOXACILLINflucloxacillin 500 mg capsule, 24 | 1 | 24 | 0 |
| MPNP | 1524F | FLUCLOXACILLINflucloxacillin 500 mg injection, 5 x 500 mg vials | 1 | 5 | 0 |
| MPNP | 1472L | FLUCONAZOLEfluconazole 100 mg capsule, 28 | 1 | 28 | 5 |
| MPNP | 1473M | FLUCONAZOLEfluconazole 100 mg/50 mL injection, 1 x 50 mL vial | 7 | 7 | 0 |
| MPNP | 1475P | FLUCONAZOLEfluconazole 200 mg capsule, 28 | 1 | 28 | 5 |
| MPNP | 1474N | FLUCONAZOLEfluconazole 200 mg/100 mL injection, 1 x 100 mL vial | 7 | 7 | 0 |
| MPNP | 1757L | FLUCONAZOLEfluconazole 400 mg/200 mL injection, 1 x 200 mL bag | 1 | 1 | 0 |
| MPNP | 1471K | FLUCONAZOLEfluconazole 50 mg capsule, 28 | 1 | 28 | 5 |
| MPNP | 5446P | FLUCONAZOLEfluconazole 50 mg/5 mL oral liquid: powder for, 35 mL | 1 | 1 | 0 |
| MPNP | 1433K | FLUDROCORTISONE ACETATEfludrocortisone acetate 100 microgram tablet, 100 | 2 | 200 | 1 |
| MPNP | 1204J | FLUOROMETHOLONEfluorometholone 0.1% (1 mg/mL) eye drops, 5 mL | 1 | 1 | 5 |
| MPNP | 1438Q | FLUOROMETHOLONE ACETATEfluorometholone acetate 0.1% (1 mg/mL) eye drops, 5 mL | 1 | 1 | 2 |
| MPNP | 1434L | FLUOXETINEfluoxetine 20 mg capsule, 28 | 1 | 28 | 5 |
| MPNP | 8270G | FLUOXETINEfluoxetine 20 mg tablet: dispersible, 28 | 1 | 28 | 5 |
| MPNP | 2257T | FLUPENTHIXOL DECANOATEflupenthixol decanoate 100 mg/mL injection, 5 x 1 mL ampoules | 1 | 5 | 0 |
| MPNP | 2255Q | FLUPENTHIXOL DECANOATEflupenthixol decanoate 20 mg/mL injection, 5 x 1 mL ampoules | 1 | 5 | 0 |
| MPNP | 1046C | FLUPHENAZINE DECANOATEfluphenazine decanoate 12.5 mg/0.5 mL injection, 5 x 0.5 mL ampoules | 1 | 5 | 0 |
| MPNP | 3098C | FLUPHENAZINE DECANOATEfluphenazine decanoate 25 mg/mL injection, 5 x 1 mL ampoules | 1 | 5 | 0 |
| MPNP | 1001Q | FLUPHENAZINE DECANOATEfluphenazine decanoate 50 mg/2 mL injection, 5 x 2 mL ampoules | 1 | 5 | 0 |
| MPNP | 8699W | FLURBIPROFENflurbiprofen sodium 0.03% (120 microgram/0.4 mL) eye drops, 5 x 0.4 mL ampoules | 1 | 1 | 0 |
| MPNP | 1417N | FLUTAMIDEflutamide 250 mg tablet, 100 | 1 | 100 | 5 |
| MPNP | 8147T | FLUTICASONEfluticasone propionate 100 microgram/actuation inhalation: powder for, 60 actuations | 1 | 1 | 5 |
| MPNP | 8345F | FLUTICASONEfluticasone propionate 125 microgram/actuation inhalation: pressurised, 120 actuations | 1 | 1 | 5 |
| MPNP | 8148W | FLUTICASONEfluticasone propionate 250 microgram/actuation inhalation: powder for, 60 actuations | 1 | 1 | 5 |
| MPNP | 8346G | FLUTICASONEfluticasone propionate 250 microgram/actuation inhalation: pressurised, 120 actuations | 1 | 1 | 1 |
| MPNP | 8516F | FLUTICASONEfluticasone propionate 50 microgram/actuation inhalation: pressurised, 120 actuations | 1 | 1 | 5 |
| MPNP | 8149X | FLUTICASONEfluticasone propionate 500 microgram/actuation inhalation: powder for, 60 actuations | 1 | 1 | 1 |
| MPNP | 8430Q | FLUTICASONE + SALMETEROLfluticasone propionate 100 microgram/actuation + salmeterol 50 microgram/actuation inhalation: powder for, 60 actuations | 1 | 1 | 5 |
| MPNP | 8518H | FLUTICASONE + SALMETEROLfluticasone propionate 125 microgram/actuation + salmeterol 25 microgram/actuation inhalation: pressurised, 120 actuations | 1 | 1 | 5 |
| MPNP | 8519J | FLUTICASONE + SALMETEROLfluticasone propionate 250 microgram/actuation + salmeterol 25 microgram/actuation inhalation: pressurised, 120 actuations | 1 | 1 | 5 |
| MPNP | 8431R | FLUTICASONE + SALMETEROLfluticasone propionate 250 microgram/actuation + salmeterol 50 microgram/actuation inhalation: powder for, 60 actuations | 1 | 1 | 5 |
| MPNP | 8517G | FLUTICASONE + SALMETEROLfluticasone propionate 50 microgram/actuation + salmeterol 25 microgram/actuation inhalation: pressurised, 120 actuations | 1 | 1 | 5 |
| MPNP | 8432T | FLUTICASONE + SALMETEROLfluticasone propionate 500 microgram/actuation + salmeterol 50 microgram/actuation inhalation: powder for, 60 actuations | 1 | 1 | 5 |
| MPNP | 8023G | FLUVASTATINfluvastatin 20 mg capsule, 28 | 1 | 28 | 5 |
| MPNP | 8024H | FLUVASTATINfluvastatin 40 mg capsule, 28 | 1 | 28 | 5 |
| MPNP | 2863Q | FLUVASTATINfluvastatin 80 mg tablet: modified release, 28 tablets | 1 | 28 | 5 |
| MPNP | 8174F | FLUVOXAMINEfluvoxamine maleate 100 mg tablet, 30 | 1 | 30 | 5 |
| MPNP | 8512B | FLUVOXAMINEfluvoxamine maleate 50 mg tablet, 30 | 1 | 30 | 5 |
| MPNP | 1437P | FOLIC ACIDfolic acid 5 mg tablet, 100 | 2 | 200 | 1 |
| MPNP | 2958Q | FOLIC ACIDfolic acid 500 microgram tablet, 100 | 2 | 200 | 0 |
| MPNP | 8775W | FONDAPARINUXFONDAPARINUX SODIUM Injection 2.5 mg in 0.5 mL single dose pre-filled syringe, 2 | 3.5 | 7 | 0 |
| MPNP | 1182F | FOSINOPRILfosinopril sodium 10 mg tablet, 30 | 1 | 30 | 5 |
| MPNP | 1183G | FOSINOPRILfosinopril sodium 20 mg tablet, 30 | 1 | 30 | 5 |
| MPNP | 8400D | FOSINOPRIL + HYDROCHLOROTHIAZIDEfosinopril sodium 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 | 1 | 30 | 5 |
| MPNP | 8401E | FOSINOPRIL + HYDROCHLOROTHIAZIDEfosinopril sodium 20 mg + hydrochlorothiazide 12.5 mg tablet, 30 | 1 | 30 | 5 |
| MPMWNP | 1440T | FRAMYCETIN SULFATEframycetin sulfate 0.5% (5 mg/mL) eye/ear drops, 8 mL | 1 | 1 | 2 |
| MPNP | 2411X | FRUSEMIDEfrusemide 10 mg/mL oral liquid, 30 mL | 1 | 1 | 3 |
| MPNP | 2414C | FRUSEMIDEfrusemide 20 mg tablet, 100 | 1 | 100 | 1 |
| MPNP | 1810G | FRUSEMIDEfrusemide 20 mg tablet, 50 | 2 | 100 | 1 |
| MPNP | 2413B | FRUSEMIDEfrusemide 20 mg/2 mL injection, 5 x 2 mL ampoules | 1 | 5 | 0 |
| MPNP | 3466K | FRUSEMIDEfrusemide 20 mg/2 mL injection, 5 x 2 mL ampoules | 1 | 5 | 0 |
| MPNP | 2412Y | FRUSEMIDEfrusemide 40 mg tablet, 100 | 1 | 100 | 1 |
| MPNP | 2415D | FRUSEMIDEfrusemide 500 mg tablet, 50 | 1 | 50 | 3 |